Excipients

Sep 13, 2007
ePT--the Electronic Newsletter of Pharmaceutical Technology
More than 100 people attended this week’s Regulatory Affairs Conference by the International Pharmaceutical Excipients Council of the Americas to discuss the latest trends and challenges in the excipient supply chain.
Sep 02, 2007
Pharmaceutical Technology
By Pharmaceutical Technology Editors
This article presents collaborative positions among excipient manufacturers, drug product manufacturers, and members of the US Pharmacopeia on key issues pertaining to the control of pharmaceutical excipients stemming from a recent Pharmaceutical Quality Research Institute workshop.
Sep 01, 2007
Pharmaceutical Technology
By Pharmaceutical Technology Editors
As China emerges as a significant supplier of pharmaceutical ingredients, it must assure other countries of the safety of its excipients.
May 02, 2007
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Excipients facilitate formulation design and perform a wide range of functions to obtain desired properties for the finished drug product. The article reviews excipient development and functionality of these materials, including their importance in formulation design, potential processing challenges directly related to excipients, and therapeutic benefits.
Apr 27, 2007
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
San Juan, PR (Apr. 25)-Regulatory and quality issues were prominent discussion topics at this year?s ExcipientFest conference and exhibition.
Apr 05, 2007
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Brussels, Belgium (Mar. 22)-The European Commission?s (EC) Directorate-General for Enterprise and Industry (Brussels, Belgium) is asking manufacturers, distributors, and users of human-pharmaceutical excipients to participate in an online questionnaire on the effect of various policy options. Responses will be used to prepare a directive on good manufacturing practices (GMPs) for certain excipients.
Apr 02, 2007
Pharmaceutical Technology
China creates a potential outlet for specialty excipients as its pharmaceutical market grows.
Nov 03, 2006
ePT--the Electronic Newsletter of Pharmaceutical Technology
AAPS, San Antonio (Oct. 31)-Excipient manufacturers are raising concerns over recently adopted European guidelines, set to become effective January 1, 2007, which provide a framework and approach for dealing with genotoxic impurities in new active substances.
Oct 03, 2006
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The specialty excipients market in the United States, Western Europe, and China is valued at nearly $800 million. The authors discuss the opportunities and challenges in these markets by examining the product mix, supply base, and preferred production methods.
Oct 02, 2006
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors investigated the influence of various particle size fractions of Tamarind seed polyose (TSP) on indomethacin (IND) release from matrix tablets. They assessed the TSP fractions for swelling, density, and flow properties and the IND matrix tablets for tensile strength, friability, and release profile. Release kinetics was evaluated using Higuchi and Peppas equations. The density and flow properties showed that the size fraction affects the suitability of TSP as an entrapment polymer. The release profile showed that the release of IND from TSP matrix is swelling dependent, thereby affecting the kinetics of release.
native1_300x100
lorem ipsum